A B S T R A C T The effect of human growth hormone (HGH) on the N, P, Na, and K balance, and on the body weight (BW) of three groups of subjects was measured. In group I were nine cases (age 6-69) with HGH deficiency; in group II, eight cases (age 9-79) with normal endogenous HGH; in group III, four cases with myotonic dystrophy (age 45-51). After a 7 day control period, the hormone was administered for 7 days. Each subject was tested with three doses of HGH: dose A, 0.0168 U/kg BW"' per day; dose B, 0.0532 U/kg BW3'4 per day; dose C, 0.168 U/kg BW314 per day.
INTRODUCTION
Some evidence suggests that age, endocrine status, and genetic factors may influence the responsiveness of animal and human subjects to growth hormone (GH):' (a) The pituitary glands of adult rats contain as much GH as those of young rats (1) . Heins, Garland, and Daughaday (2) found that the in vitro responsiveness of the rat's costal cartilage to "sulfation factor" diminishes with age of the animal. Ray, Evans, and Becks (3) observed that the in vivo widening effect of bovine growth hormone (BGH), 0.8-8 mg daily for 10 days, on the proximal epiphysis of the hypophysectomized rat's tibia was only half as great in 150-day old rats as in 50-day old animals. Therefore, it is possible that cessation of growth in adult rat or man may result in part from a diminishing responsiveness of the peripheral tissues to GH with age. (b) Rimoin, Merimee, Rabinowitz, Cavalli- day for [1] [2] [3] [4] [5] (8) found that children treated with glucocorticoids showed little or no positive balance of N, K, or P in response to (9, 10) . The latter test in male subjects was preceded by 2-days' treatment with stilbestrol (2.5 mg twice a day). Two such provocative tests were done with insulin. Blood glucose concentration declined below 40% of the zero hour value in each such procedure. In group I subjects, two provocative tests with arginine were also done. Subj ects in group I had less than 2.0 mag HGH/ml plasma in all foursample tests. Subjects in group II and III showed a peak HGH value of > 10 mug/ml in at least one insulin test. Diagnosis of HGH deficiency in subjects 17 yr or younger was supported in every instance by retardation of growth (height more than three standard deviations below the mean of the population of their age; growth rate less than 2 cm per yr; bone age less than 75% of chronological age by the criteria of Greulich and Pyle [11] ). (b) TSH (thyroid-stimulating hormone) function was evaluated in all subjects by serum thyroxine-iodine concentration (T4-I) and by thyroidal uptake of .3.I at 24 hr. Subnormal T4-I and "31I uptake occurred in five members of group I, leading to diagnosis of TSH deficiency and replacement therapy with desiccated thyroid (60-180 mg daily). T4-I in all subjects was within the normal range (2.9-6.4 fig per 100 ml) during the period of this study.
(c) ACTH function was evaluated in all subjects by fasting plasma-cortisol concentration and 24 hr urinary excretion of 17-hydroxycorticosteroids; in group I subjects, in addition, we measured the urinary 17-hydroxycorticosteroid response to metyrapone, utilizing the technique and criteria of Goodman, Grumbach, and Kaplan (12) . Subnormal response to metyrapone by the criteria cited and in some cases subnormal plasma-cortisol concentration and subnormal 24 hr urinary 17-hydroxycorticosteroid content, occurred in five members of group I and led to replacement treatment with hydrocortisone, 10-20 mg/day. In all cases, plasma-cortisol concentration and urinary 17-hydroxycorticosteroid excretion were in the normal range during the period of this study.
(d) Gonadotropin deficiency was considered to be present in subjects over 16 yr old when secondary sexual characteristics had failed to develop and less than 6-mouse uterine U of gonadotropin activity were present in a 24-hr urine sample.
(e) Diabetes insipidus was diagnosed in three cases of group I after excision of craniopharyngioma on the basis of polydypsia, excretion of over 5 liter urine a day with specific gravity less than 1.010, and correction of polyuria and polydypsia by intramuscular injection of 2.5-5.0 U pitressin tannate in oil. Such injections every 48-72 hr were used to treat the condition. NaCl at a concentration of 1-2 U/ml, was injected intramuscularly at 8 a.m.). The data of the first 2 days of the control and experimental periods were considered to represent equilibration (see Table II ) ; the effects of the specified dose of HGH upon the subject's N, P, Na, and K balances were therefore calculated from the data of the last 5 days of the control and experimental periods. Patients were weighed daily before breakfast in order to evaluate weight gain (the basis of a popular GH assay method in the rat [15] ) as a possible index of response to HGH. Thus the subject's response to one dose of HGH was measured on each hospitalization (involving 14 days of metabolic balance study) ; to determine the "full" dose response curve to all three doses, the patient was hospitalized three times at 2-to 3-month intervals. In 11 patients, after completion of three admissions, the response to two or three doses of HGH was determined again on subsequent admissions, in order to evaluate the reproducibility of the measurement of response. All replicate experiments in a given subject were done within a 14 month period.
N, P, Na, and K in diet, urine, and stool were measured according to .
RESULTS
Balance data A representative protocol is shown in Table II The responses of all nine subjects in group I are shown in Fig. 1. In general, BW2/3 (13) . ' The numerical data showing N, P, Na, K, and BW responses to doses A, B, and C for all 21 subjects, including replicate experiments, have been deposited with the National Auxiliary Publication Service, No. 01406. This appendix expresses the response as average -SE, and also gives P value for the significance of each response. 4P < 0.05 for the increase in N balance was used as a criterion for a significant response. In 84% of instances, such a N response was associated with a significant (P <0.05) increase in phosphorus balance; in 86 and 88% of instances, with a significant (P < 0.05) response in balances of Na and K, respectively. were observed, usually including: bursts of 14 (21), was found. The degree of myotonia of the hands also seemed unchanged. All four patients, nevertheless, reported that they fatigued less easily and felt "stronger" while being treated with dose C and occasionally with dose B.
Measurements of motor performances, such as ambulation and stair-climbing times, degrees of active range of motion of selected joints, and the timed capacity to rise from a chair and from the floor, were all inconclusive. Retention of more Na than K in human subjects during treatment with HGH has been observed previously (10, 24, 25 (Table III) . This suggests that the composition of the protoplasm, and the ratio of extracellular fluid to protoplasm, accumulated in response to HGH, was generally similar in the various types of subject under study. While the nature of the response thus appeared similar in all the subjects, the magnitude of the response varied with age, endocrine status, and presence of muscle disease (Fig. 1): (a) In group I, advancing age tended to be associated with diminishing responsiveness to all three dosages of HGH. (b) The members of group II exhibited a smaller response to dose A, B, or C than members of group I of comparable age. (c) The responses of the subjects of Group III (aged 45-51) were comparable to those of the 6-yr old GH-deficient subjects of group I and greater than those of all other persons tested in group I or group II.
1. In the GH-deficient subjects (group I), the correlation coefficients for the relationship between age and AN, AP, ANa, or AK at each dose of HGH were uniformly negative, ranging between -0.358 and -0.761. In 8 of 12 instances (4 indicators of response at 3 dosages), the P value for significance of this negative correlation was < 0.05. In groups II and III, no statistically significant correlation between age and response was evident. While these findings raise the possibility that in GH-deficient subjects, the responsiveness to exogenous HGH may diminish with age, there are several reasons why a firm conclusion on this matter is not warranted at present. The statistical significance of the inverse correlation was not convincing, generally not reaching the 1% level. Furthermore, the nine subjects of group I did not represent a balanced sampling of the age span under consideration, since five patients were clustered at age 15-17, and two patients at age 6. Finally, the apparent decline in responsiveness might not be an effect of age per se, but could instead be related to the duration of exogenous cortisol therapy or to the length of time during which endogenous GH had been secreted at a normal rate. Accordingly, a larger series will need to be studied before final conclusions can be made about the possible age-dependence of responsiveness to HGH in GH-deficient subjects.
2. A greater responsiveness to exogenous HGH of the individual lacking endogenous HGH was evident at all dosages of HGH up to the age of 17. Our subjects over 40 (2 in group I vs. 3 in group II) did not show this difference. Further cases will need to be tested before conclusions can be made about the relationship between endogenous HGH function and responsiveness to exogenous HGH during adulthood. The present evidence that GH deficiency enhances responsiveness of children to exogenous HGH confirms the conclusions of Prader et al. (6) and Brown and coworkers (7).
3. The hyperresponsiveness of adults with myotonic dystrophy was an unanticipated finding but was uniform in all four (unrelated) cases studied. The significance of this characteristic of these patients will not be known until further work is done. Muscle cells of the rat are highly sensitive to BGH, which stimulates amino acid uptake and synthesis of a variety of proteins by these cells (26) . The major portion of the positive N, P, and K balance produced by BGH in the hypopituitary rat reflects the deposition of muscle protoplasm (27) . The marked increments in these balances in the myotonicdystrophy patients may therefore reflect a hyperresponsiveness of their muscle cells to HGH. The simultaneous retention -of Na in a ANa/AN ratio of about 10, suggests a greater than normal responsiveness of these patients to the effects of HGH on extracellular volume as well as on formation of protoplasm. The insulin-provocative tests indicated normal endogenous GH function in these patients,5 so that hyperresponsiveness cannot be ascribed to deficiency of endogenous GH; in any case, their responses far exceed those of even GH-deficient subjects > 20 yr in age. Perhaps the unknown biochemical lesion in the myotonic-dystrophy muscle cell is palliated or corrected by HGH with resulting rapid deposition of protein in these cells. If this interpretation should be correct, then long-term treatment of these patients with HGH might benefit the muscle disease. Improvement in the prolonged PR interval in the three myotonic dystrophy cases with first degree heart block, supports this conjecture. On the other hand, one could reason that an abnormal hyperresponsiveness of muscle cells to HGH may have predisposed to, or played a role in the development of, the degenerative disease of the muscle cells. Should this be the case, treatment with HGH could prove to have a detrimental rather than beneficial effect on myotonic dystrophy. Finally, the hyperresponsiveness to HGH may be a nonspecific consequence of atrophy or disuse of muscle, rather than a unique characteristic of the myotonic dystrophy patient. To examine this possibility, patients with other types of atrophic muscle disease are currently under study.
The presence of anemia in all GH deficient children studied, and improvement in the anemia in four cases reexamined 23-30 days after dose C, suggest that HGH may stimulate erythropoiesis in man. This possibility is supported by the observations of Meineke and Crafts (28) and of Fruhman, Gertsner, and Gordon (29) with BGH in the hypophysectomized rat.
